MANAPPURAM.BO

Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 55/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

7/7 Very High

7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.8x).

Beta (Market Relation)

0.82x

Defensive

Volatility (5Y p.a.)

37.9% p.a.

5-Year Horizon

Max Drawdown (5Y)

-62.6%

5-Year Horizon

Sharpe Ratio

0.19

Return / Risk

Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	+4%
3 Years	37.3%	-38.9%	0.73	+29.6%
5 Years	37.9%	-62.6%	0.19	+9.5%
10 Years	42.2%	-62.6%	0.24	+12.8%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 360%.

Strong cyclicality: The business model is sensitive to economic downturns.

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (37.9% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -62.6% in the extended horizon.